149 related articles for article (PubMed ID: 26968790)
21. Effects of Gram-negative Rod Blood Stream Infection on Acute GVHD in Allogeneic Hematopoietic Stem Cell Transplantation: A Single-institute Analysis.
Nishinohara M; Nishimori H; Fujiwara H; Asada N; Ennishi D; Matsuoka KI; Fujii K; Fujii N; Maeda Y
Acta Med Okayama; 2021 Jun; 75(3):279-287. PubMed ID: 34176931
[TBL] [Abstract][Full Text] [Related]
22. Bacterial infections in pediatric hematopoietic stem cell transplantation recipients: incidence, epidemiology, and spectrum of pathogens: report of the Polish Pediatric Group for Hematopoietic Stem Cell Transplantation.
Zając-Spychała O; Wachowiak J; Pieczonka A; Siewiera K; Frączkiewicz J; Kałwak K; Gorczyńska E; Chybicka A; Czyżewski K; Jachna-Sawicka K; Wysocki M; Klepacka J; Goździk J; Zaucha-Prażmo A; Kowalczyk JR; Styczyński J
Transpl Infect Dis; 2016 Oct; 18(5):690-698. PubMed ID: 27479544
[TBL] [Abstract][Full Text] [Related]
23. Alemtuzumab as graft-versus-host disease (GVHD) prophylaxis strategy in a developing country: lower rate of acute GVHD, increased risk of cytomegalovirus reactivation.
Resende CB; Rezende BM; Bernardes PT; Teixeira GM; Teixeira MM; Pinho V; Bittencourt H
Braz J Med Biol Res; 2017 Feb; 50(2):e5566. PubMed ID: 28198910
[TBL] [Abstract][Full Text] [Related]
24. Long-term follow-up of patients treated with daclizumab for steroid-refractory acute graft-vs-host disease.
Perales MA; Ishill N; Lomazow WA; Weinstock DM; Papadopoulos EB; Dastigir H; Chiu M; Boulad F; Castro-Malaspina HR; Heller G; Jakubowski AA; O'Reilly RJ; Small TN; Young JW; Kernan NA
Bone Marrow Transplant; 2007 Sep; 40(5):481-6. PubMed ID: 17618322
[TBL] [Abstract][Full Text] [Related]
25. Steroid treatment of acute graft-
Bacigalupo A; Milone G; Cupri A; Severino A; Fagioli F; Berger M; Santarone S; Chiusolo P; Sica S; Mammoliti S; Sorasio R; Massi D; Van Lint MT; Raiola AM; Gualandi F; Selleri C; Sormani MP; Signori A; Risitano A; Bonifazi F;
Haematologica; 2017 Dec; 102(12):2125-2133. PubMed ID: 28971905
[TBL] [Abstract][Full Text] [Related]
26. Correlations of human herpesvirus 6B and CMV infection with acute GVHD in recipients of allogeneic haematopoietic stem cell transplantation.
Wang LR; Dong LJ; Zhang MJ; Lu DP
Bone Marrow Transplant; 2008 Nov; 42(10):673-7. PubMed ID: 18695666
[TBL] [Abstract][Full Text] [Related]
27. Once-weekly liposomal amphotericin B for prophylaxis of invasive fungal infection after graft-versus-host disease in allogeneic hematopoietic stem cell transplantation: a comparative retrospective single-center study.
El Cheikh J; Castagna L; Wang L; Esterni B; Faucher C; Furst S; Duran S; Berger P; Ranque S; Mohty M; Blaise D
Hematol Oncol Stem Cell Ther; 2010; 3(4):167-73. PubMed ID: 21150235
[TBL] [Abstract][Full Text] [Related]
28. Role of acute graft-versus-host disease in the risk of bacteremia and invasive fungal disease after allogeneic hemopoietic stem cell transplantation in children. Results from a single-center observational study.
Castagnola E; Bagnasco F; Bandettini R; Caviglia I; Morreale G; Lanino E; Giardino S; Moroni C; Haupt R; Faraci M
Biol Blood Marrow Transplant; 2014 Jul; 20(7):1068-73. PubMed ID: 24691219
[TBL] [Abstract][Full Text] [Related]
29. Beneficial Role of Low-Dose Antithymocyte Globulin in Unrelated Stem Cell Transplantation for Adult Patients with Acquired Severe Aplastic Anemia: Reduction of Graft-versus-Host Disease and Improvement of Graft-versus-Host Disease-Free, Failure-Free Survival Rate.
Park SS; Kwak DH; Jeon YW; Yoon JH; Lee SE; Cho BS; Eom KS; Kim YJ; Kim HJ; Lee S; Min CK; Cho SG; Kim DW; Min WS; Lee JW
Biol Blood Marrow Transplant; 2017 Sep; 23(9):1498-1508. PubMed ID: 28554856
[TBL] [Abstract][Full Text] [Related]
30. Initial therapy of acute graft-versus-host disease with low-dose prednisone does not compromise patient outcomes.
Mielcarek M; Storer BE; Boeckh M; Carpenter PA; McDonald GB; Deeg HJ; Nash RA; Flowers ME; Doney K; Lee S; Marr KA; Furlong T; Storb R; Appelbaum FR; Martin PJ
Blood; 2009 Mar; 113(13):2888-94. PubMed ID: 19001082
[TBL] [Abstract][Full Text] [Related]
31. Epidemiology and Risk Factors for Invasive Fungal Diseases among Allogeneic Hematopoietic Stem Cell Transplant Recipients in Korea: Results of "RISK" Study.
Choi JK; Cho SY; Yoon SS; Moon JH; Kim SH; Lee JH; Kim JS; Cheong JW; Jang JH; Seo BJ; Kim YJ; Lee HJ; Lee J; Lee JW; Lee DG
Biol Blood Marrow Transplant; 2017 Oct; 23(10):1773-1779. PubMed ID: 28668492
[TBL] [Abstract][Full Text] [Related]
32. Incidence of invasive fungal disease after unmanipulated haploidentical stem cell transplantation was significantly higher than that after HLA-matched sibling transplantation.
Sun Y; Xu L; Liu D; Zhang X; Han W; Wang Y; Chen H; Chen Y; Wang F; Wang J; Ji Y; Tang F; Liu K; Huang XJ
Clin Microbiol Infect; 2013 Nov; 19(11):1029-34. PubMed ID: 23565830
[TBL] [Abstract][Full Text] [Related]
33. Incidence and outcome of invasive fungal diseases after allogeneic stem cell transplantation: a prospective study of the Gruppo Italiano Trapianto Midollo Osseo (GITMO).
Girmenia C; Raiola AM; Piciocchi A; Algarotti A; Stanzani M; Cudillo L; Pecoraro C; Guidi S; Iori AP; Montante B; Chiusolo P; Lanino E; Carella AM; Zucchetti E; Bruno B; Irrera G; Patriarca F; Baronciani D; Musso M; Prete A; Risitano AM; Russo D; Mordini N; Pastore D; Vacca A; Onida F; Falcioni S; Pisapia G; Milone G; Vallisa D; Olivieri A; Bonini A; Castagnola E; Sica S; Majolino I; Bosi A; Busca A; Arcese W; Bandini G; Bacigalupo A; Rambaldi A; Locasciulli A
Biol Blood Marrow Transplant; 2014 Jun; 20(6):872-80. PubMed ID: 24631738
[TBL] [Abstract][Full Text] [Related]
34. CD3+/Tregs ratio in donor grafts is linked to acute graft-versus-host disease and immunologic recovery after allogeneic peripheral blood stem cell transplantation.
Pastore D; Delia M; Mestice A; Carluccio P; Perrone T; Gaudio F; Curci P; Rossi AR; Ricco A; Specchia G
Biol Blood Marrow Transplant; 2012 Jun; 18(6):887-93. PubMed ID: 22062803
[TBL] [Abstract][Full Text] [Related]
35. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
Petersen SL
Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
[TBL] [Abstract][Full Text] [Related]
36. A prognostic score for acute graft-versus-host disease based on biomarkers: a multicentre study.
Levine JE; Braun TM; Harris AC; Holler E; Taylor A; Miller H; Magenau J; Weisdorf DJ; Ho VT; Bolaños-Meade J; Alousi AM; Ferrara JL;
Lancet Haematol; 2015 Jan; 2(1):e21-9. PubMed ID: 26687425
[TBL] [Abstract][Full Text] [Related]
37. [Cytomegalovirus diseases after allogeneic hematopoietic stem cell transplantation (Allo-HSCT) and related risk factors].
Huang XJ; Xu LP; Ren HY; Zhang YC; Guo NL; Lu DP
Zhonghua Yi Xue Za Zhi; 2003 May; 83(9):766-9. PubMed ID: 12899755
[TBL] [Abstract][Full Text] [Related]
38. Incidence and risk factors of probable and proven invasive fungal infection in adult patients receiving allogeneic hematopoietic stem cell transplantation.
Liu YC; Chien SH; Fan NW; Hu MH; Gau JP; Liu CJ; Yu YB; Liu CY; Hsiao LT; Liu JH; Chiou TJ; Chen PM; Tzeng CH
J Microbiol Immunol Infect; 2016 Aug; 49(4):567-74. PubMed ID: 25735797
[TBL] [Abstract][Full Text] [Related]
39. Association between acute graft versus host disease and lung injury after allogeneic haematopoietic stem cell transplantation.
Liu QF; Luo XD; Ning J; Xu D; Fan ZP; Sun J; Zhang Y; Xu B; Wei YQ
Hematology; 2009 Apr; 14(2):63-72. PubMed ID: 19298716
[TBL] [Abstract][Full Text] [Related]
40. Comparison of outcomes after donor lymphocyte infusion with or without prior chemotherapy for minimal residual disease in acute leukemia/myelodysplastic syndrome after allogeneic hematopoietic stem cell transplantation.
Mo XD; Zhang XH; Xu LP; Wang Y; Yan CH; Chen H; Chen YH; Han W; Wang FR; Wang JZ; Liu KY; Huang XJ
Ann Hematol; 2017 May; 96(5):829-838. PubMed ID: 28285386
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]